Freestone Capital Holdings’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$243K Hold
18,655
0.01% 393
2025
Q1
$198K Hold
18,655
0.01% 421
2024
Q4
$317K Hold
18,655
0.01% 342
2024
Q3
$433K Buy
18,655
+200
+1% +$4.64K 0.01% 308
2024
Q2
$449K Buy
+18,455
New +$449K 0.02% 311